MicroRNA-33a negatively regulates myoblast proliferation by targeting IGF1, follistatin and cyclin D1
Open Access
- 4 June 2020
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 40 (6)
- https://doi.org/10.1042/bsr20191327
Abstract
MiR-33a is found as a regulator of cell proliferation in many cancer cells. However, it remains unknown if and how miR-33a plays a role in myoblasts proliferation. To investigate the effect of miR-33a on myoblasts proliferation, miR-33a mimic or inhibitor was co-administered with or without insulin-like growth factor 1 (IGF1) to simulation myoblasts. Our study showed that upregulation of miR-33a impaired myoblasts proliferation, while downregulation of miR-33a enhanced myoblasts proliferation. Mechanistically, we examined that miR-33a can inhibit the transcription of IGF1, follistatin (FST) and cyclin D1 (CCND1) by targeting their 3'UTR region in both HEK293T cells and duck myoblasts. Moreover, upregulation of miR-33a decreased and its downregulation increased the mRNA expression of PI3K, Akt, mTOR and S6K. Importantly, the decreased PI3K, Akt, mTOR and S6K expression by miR-33a mimics was abrogated by co-administered with IGF1. Altogether, our results demonstrated that miR-33a may directly target IGF1, FST and CCND1 to inhibit myoblasts proliferation via PI3K/Akt/mTOR signaling. In conclusion, miR-33a is a potential negative regulator of myoblasts proliferation and by modulating its expression. miR-33a could play an important role in promoting the early development of skeletal muscle.Keywords
This publication has 33 references indexed in Scilit:
- miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle developmentCell Death & Disease, 2013
- Characterization of in vitro cultured myoblasts isolated from duck (Anas platyrhynchos) embryoCytotechnology, 2011
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signalingProceedings of the National Academy of Sciences of the United States of America, 2011
- microRNAs and cholesterol metabolismTrends in Endocrinology & Metabolism, 2010
- Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiationCell Death & Differentiation, 2009
- SMYD1, the myogenic activator, is a direct target of serum response factor and myogeninNucleic Acids Research, 2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences of the United States of America, 2006
- MicroRNA biogenesis: coordinated cropping and dicingNature Reviews Molecular Cell Biology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001